Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 5 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
BIOASTER maintains a portfolio with 8 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 5 distinct art units and involve 7 distinct examiners, reflecting a broad distribution of intellectual property across different specialized groups at the USPTO. This diversity suggests that the company is pursuing multiple distinct technological paths within its sector, requiring a multifaceted prosecution strategy to manage various examiner expectations and art unit standards.
The busiest examiner for the portfolio is MYERS, CARLA J, who is currently handling 2 pending office actions. With 7 distinct examiners and 5 distinct art units in play, the company's prosecution risk is diversified, as no single individual or unit controls the majority of the 8 pending office actions. The presence of 7 distinct examiners ensures that the portfolio is subject to a wide range of examiner perspectives. This distribution across 5 distinct art units also indicates that the company's innovations span several specialized technical niches within the broader biotechnology field. This examiner's 2 pending office actions represent the highest concentration of work for any single individual in this portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (50%) |
| §103 only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MYERS, CARLA J | 2 | 49.3% | +46.1% |
| ZHANG, WAYNE | 1 | 56.0% | +40.0% |
| KIM, YOUNG J | 1 | 64.8% | +18.1% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.1% | +16.4% |
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +54.0% |
| HAMMELL, NEIL P | 1 | 34.6% | +43.0% |
| GAO, ASHLEY HARTMAN | 1 | 56.7% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18014814 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | MYERS, CARLA J | — |
| 18014878 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | KIM, YOUNG J | — |
| 18014885 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | SWITZER, JULIET CAROLINE | — |
| 18014801 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | MYERS, CARLA J | — |
| 17764323 | METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF A HEALTHCARE-ASSOCIATED INFECTION IN A PATIENT | HAMMELL, NEIL P | — |
| 17294327 | METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS | GAO, ASHLEY HARTMAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031972 | METHOD FOR CLASSIFYING AN INPUT IMAGE REPRESENTING A PARTICLE IN A SAMPLE | ZHANG, WAYNE | 27d |
| 18014814 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | MYERS, CARLA J | — |
| 18014878 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | KIM, YOUNG J | — |
| 18014934 | METHOD FOR DETERMINING THE RISK OF COMPLICATION IN A PATIENT | KINSEY WHITE, NICOLE ERIN | — |
| 18014885 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | SWITZER, JULIET CAROLINE | — |
| 18014801 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | MYERS, CARLA J | — |
| 17764323 | METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF A HEALTHCARE-ASSOCIATED INFECTION IN A PATIENT | HAMMELL, NEIL P | — |
| 17294327 | METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS | GAO, ASHLEY HARTMAN | — |
| Art Unit | Apps |
|---|---|
| 1682 | 3 |
| 1681 | 2 |
| 2672 | 1 |
| 1672 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18031972 | METHOD FOR CLASSIFYING AN INPUT IMAGE REPRESENTING A PARTICLE IN A SAMPLE | ZHANG, WAYNE | 2672 | §103 | Final Rejection | 27d | Pending | Apr 14, 2023 |
| 18014814 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | MYERS, CARLA J | 1682 | §101§102§112Other | Non-Final OA | — | Pending | Jan 06, 2023 |
| 18014878 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | KIM, YOUNG J | 1681 | §103§112 | Final Rejection | — | Pending | Jan 06, 2023 |
| 18014934 | METHOD FOR DETERMINING THE RISK OF COMPLICATION IN A PATIENT | KINSEY WHITE, NICOLE ERIN | 1672 | §103§112DP | Final Rejection | — | Pending | Jan 06, 2023 |
| 18014885 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | SWITZER, JULIET CAROLINE | 1682 | §101§103§112DPOther | Final Rejection | — | Pending | Jan 06, 2023 |
| 18014801 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT | MYERS, CARLA J | 1682 | §101§102§112Other | Non-Final OA | — | Pending | Jan 06, 2023 |
| 17764323 | METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF A HEALTHCARE-ASSOCIATED INFECTION IN A PATIENT | HAMMELL, NEIL P | 1681 | §101§112 | Final Rejection | — | Pending | Mar 28, 2022 |
| 17294327 | METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS | GAO, ASHLEY HARTMAN | 1678 | §103§112 | Final Rejection | — | Pending | May 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial